Abstract
Due to the high incidence and prevalence of the low back chronic pain and multiple side effects due to drugs used in this disease, an increase in use of other therapeutic alternatives as glucosamine have been seen Glucosamine is used more frequently, nonetheless the main question is if it is effective or not for reduction of symptomatology in this disease. In the next article we present a short review and analysis current literature, to give in a critical way and a structured vision of the efficacy of this drug for chronic low back pain. Two systematic reviews were found, and they included four randomized clinical trials. Two of them with good quality and with low risk of bias. Two studies reported that there was no difference between the use of glucosamine vs placebo for chronic low back pain secondary to osteoarthrosis. The other two, did not have good quality nor external validity, both, necessary elements to justify the use of glucosamine. There is no scientific evidence with good quality that justify the use of glucosamine in chronic low back pain associated with osteoarthrosis.
References
Huskisson EC. Glucosamine and chondroitin for osteoarthritis. J Int Med Res. 2008;36(6):1161-79. https://doi.org/10.1177/147323000803600602
Goode AP, Carey TS, Jordan JM. Low back pain and lumbar spine osteoarthritis: how are they related? Curr Rheumatol Rep. 2013;15(2):305. https://doi.org/10.1007/s11926-012-0305-z
Laine L. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors. Semin Arthritis Rheum. 2002;32(3 Suppl 1):25-32. https://doi.org/10.1053/sarh.2002.37217
Lichtenstein DR, Syngal S, Wolfe MM. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword. Arthritis Rheum. 1995;38(1):5-18. https://doi.org/10.1002/art.1780380103
Stuber K, Sajko S, Kristmanson K. Efficacy of glucosamine, chondroitin, and methylsulfonylmethane for spinal degenerative joint disease and degenerative disc disease: a systematic review. J Can Chiropr Assoc. 2011;55(1):47-55.
Pavelká K, Gatterová J, Olejarová M, Machacek S, Giacovelli G, Rovati LC. Glucosamine sulfate use and delay of progression of knee osteoarthritis: A 3-year, randomized, placebo-controlled, double-blind study. Archives of Internal Medicine. 2002;162(18):2113-23. https://doi.org/10.1001/archinte.162.18.2113
McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: A systematic quality assessment and meta-analysis. JAMA. 2000;283(11):1469-75. https://doi.org/10.1001/jama.283.11.1469
Wilkens P, Scheel IB, Grundnes O, Hellum C, Storheim K. Effect of glucosamine on pain-related disability in patients with chronic low back pain and degenerative lumbar osteoarthritis: A randomized controlled trial. JAMA. 2010;304(1):45-52. https://doi.org/10.1001/jama.2010.893
Albert HB, Manniche C. Modic changes following lumbar disc herniation. European Spine Journal. 2007;16(7):977-82. https://doi.org/10.1007/s00586-007-0336-8
Kjaer P, Leboeuf-Yde C, Korsholm L, Sorensen JS, Bendix T. Magnetic resonance imaging and low back pain in adults: a diagnostic imaging study of 40-year-old men and women. Spine (Phila Pa 1976). 2005;30(10):1173-80. https://doi.org/10.1097/01.brs.0000162396.97739.76
Wilkens P, Storheim K, Scheel I, Berg L, Espeland A. No effect of 6-month intake of glucosamine sulfate on Modic changes or high intensity zones in the lumbar spine: sub-group analysis of a randomized controlled trial. Journal of Negative Results in Biomedicine. 2012;11:13. https://doi.org/10.1186/1477-5751-11-13
OCEBM Levels of Evidence Working Group*. "The Oxford 2011 Levels of Evidence". Oxford Centre for Evidence-Based Medicine. 2011 [Citada 5 de junio de 2017] .Disponible en: https://www.cebm.net/wp-content/uploads/2014/06/CEBM-Levels-of-Evidence-2.1.pdf
Sodha R, Sivanadarajah N, Alam M. The use of glucosamine for chronic low back pain: a systematic review of randomised control trials. BMJ Open. 2013;3(6):e001167. https://doi.org/10.1136/bmjopen-2012-001167